Peptide United

The research
record for
peptide science.

102 evidence-graded profiles. Every mechanism traced to primary literature. Free to read.

102profiles
16categories
1,200+citations
Index
All 102+ →

Specimen index

All 102+ →

ACE-031

Phase II

ACVR2B-Fc · Bimagrumab-precursor

ACE-031 is a fusion protein of the extracellular domain of activin type IIB receptor (ACVR2B) fused to human IgG1 Fc. It acts as a myostatin/activin trap, sequestering multiple TGF-β superfamily ligands (myostatin, GDF-11, activin A) that inhibit muscle growth. Phase 2 trials in Duchenne muscular dystrophy showed significant lean muscle mass gains before being halted for safety signals (nosebleeds, telangiectasias). Related compound bimagrumab continues development.

Muscle & Performance

ACTH

Approved

Adrenocorticotropic Hormone · Corticotropin

ACTH is a 39-amino-acid peptide hormone released by the anterior pituitary in response to CRH. Its primary role is stimulating the adrenal cortex to produce cortisol, but it also has direct melanotropic and lipolytic effects. Synthetic forms (cosyntropin) are used diagnostically for adrenal insufficiency testing. Longer-acting formulations (H.P. Acthar Gel) are approved for multiple sclerosis relapses, infantile spasms, and various inflammatory conditions.

Anti-Aging & LongevityHealing & Recovery

Adrenomedullin

Phase II

AM

Adrenomedullin is a 52-amino-acid vasoactive peptide originally isolated from human pheochromocytoma. It is a potent vasodilator acting through CGRP receptors, promotes natriuresis, reduces inflammation, protects vascular endothelial barrier function, and enhances wound healing. Circulating AM levels rise in heart failure, sepsis, and critical illness — making it both a biomarker and emerging therapeutic target.

CardiovascularHealing & Recovery

Angiotensin 1-7

Phase II

Ang(1-7) · A779 counter-regulatory

Angiotensin 1-7 is a 7-amino-acid peptide of the renin-angiotensin system (RAS) and the primary product of ACE2 enzyme activity. It opposes the vasoconstrictive, pro-inflammatory actions of Angiotensin II by acting on the Mas receptor — promoting vasodilation, natriuresis, anti-fibrosis, and anti-inflammation. Extensively studied for heart failure, hypertension, and COVID-19, it represents the counter-regulatory arm of the RAS.

CardiovascularAnti-Aging & Longevity

ANP

Approved

Atrial Natriuretic Peptide · ANF

ANP (Atrial Natriuretic Peptide) is a 28-amino-acid cardiac hormone secreted by atrial cardiomyocytes in response to volume overload. It reduces blood pressure through natriuresis, vasodilation, and inhibition of the RAAS. Carperitide (synthetic ANP) is approved in Japan for acute heart failure. ANP is a key biomarker and drug target for heart failure and hypertension, studied alongside BNP and C-type natriuretic peptide.

Cardiovascular

Anserine

Preclinical

Beta-Alanyl-N-methyl-L-histidine

Anserine is a methylated dipeptide analog of carnosine found in high concentrations in avian and fish muscle. It shares carnosine's pH-buffering and antioxidant properties but shows superior blood-brain barrier penetration. Research highlights potential for cognitive decline prevention, reduction of amyloid-beta toxicity, and improved exercise performance. It is often studied alongside carnosine for synergistic effects.

Anti-Aging & LongevityMuscle & PerformanceNeuroprotection

AOD-9604

Phase III

Anti-Obesity Drug 9604 · hGH Fragment 177-191

AOD-9604 is a modified fragment of human growth hormone (hGH 177-191) that retains the lipolytic properties of GH without its anabolic or diabetogenic effects. It stimulates lipolysis through β3-adrenergic receptor pathways and inhibits lipogenesis. Phase 3 trials for obesity were conducted; it has since been investigated for osteoarthritis through cartilage repair properties.

Fat Loss & Metabolic

Apelin

Phase I

APLNR ligand · apelin-13

Apelin is an endogenous peptide that acts as the ligand for the APJ receptor (APLNR), a GPCR expressed throughout the cardiovascular system. It improves cardiac output and vascular tone through both positive inotropy and vasodilation, increases nitric oxide production, and reduces oxidative stress. Research focuses on heart failure, pulmonary arterial hypertension, and its potential to replace or complement established cardiac peptides.

Cardiovascular

Editorial

How this works.

Every profile starts with a PubMed search — not a supplier's product page. We identify the primary literature, note the study design (in vitro, animal model, or human trial), and rate the evidence accordingly. You will always know whether a claim comes from a rat study or a randomized controlled trial.

Profiles follow a fixed structure: mechanism of action, pharmacokinetics (half-life, bioavailability, routes of administration), clinical evidence with direct study links, and a standardized safety profile. The format does not change based on commercial interest in the compound.

Vetted suppliers appear in our partner directory because they publish third-party certificates of analysis and pass our sourcing review — not because they advertise with us. Research profiles are written before any commercial relationship is established, and editorial findings are never altered by partner status.

If you find an error — a miscited study, an outdated half-life figure, a mechanism described incorrectly — email us. We correct it publicly and note the revision in the profile.

PubMed-sourced

Every citation links to its primary study

Standardized format

Same structure, every profile

No paid placements

Editorial independent of supplier relationships

Researcher plan

Free summaries say what.
Full profiles say why.

The free tier covers research status, an overview, and administration routes. The Researcher plan adds the full mechanism of action, pharmacokinetic data, direct PubMed study links with evidence grades, and the compound comparison tool. $12/month.

Research profile

Preclinical

BPC-157

Free

A 15-amino acid partial sequence of Body Protection Compound, derived from human gastric juice. Studied extensively in rodent models for tissue repair, tendon healing, and gastrointestinal protection.

Mechanism of action

BPC-157 upregulates vascular endothelial growth factor (VEGF) and its receptor VEGFR2, promoting angiogenesis at injury sites. It also sensitizes growth hormone receptors on tendon fibroblasts via the FAK-paxillin pathway, and modulates nitric oxide synthesis through…

Researcher plan

Unlock for $12/mo →

“The mechanism breakdowns go further than anything I’ve found outside of primary literature. I’ve started sending patients here before appointments.”

Functional medicine practitioner

PubMed-linked profiles cut my pre-protocol research time in half.

PhD researcher, biochemistry

Finally something I can share with colleagues. No anecdotes dressed up as evidence.

Compounding pharmacist

New peptide research, once a week.

PubMed updates and new profiles. Not a sales email.

New peptide research, once a week.

PubMed updates, new compound profiles, and research summaries. Not a newsletter about selling you something.

No spam. Unsubscribe any time.

Start with the database.

Every profile has a free summary. No account required.

Browse 102 peptides →